This week news of a new treatment for insomnia; The FDA comment on magnesium hypertension claims; Transmucosal buprenorphine linked to dental decay; Researchers assess changes in menstrual cycles in relation to COVID vaccines; And experts have their say on the best diets for 2022.
The strength of the scientific evidence supporting the relationship will be disclosed as “supportive but inconclusive” to avoid misleading consumers.
The researchers examined data from the National Health and Nutrition Examination Survey.
Rates of BP control lower for current smokers; 45.5 percent of men had blood pressure >180 and/or >100 mm Hg
The new packaging allows for ease of administration and convenience.
N-nitroso-irbesartan is a probable human carcinogen based on results from laboratory tests.
Meta-analysis shows ACE inhibitors, ß-blockers, calcium-channel blockers, thiazide diuretics associated with increased risk for psoriasis
Bigger drop in systolic BP but less intensification sustainability seen with addition of new med versus maximizing dose of current med
Relative to those with dip in nighttime SBP, nondippers, reverse dippers have higher prevalence of cardiac autonomic neuropathy
Despite similar risk for albuminuria with diabetes, albumin-to-creatinine ratio screening in patients with hypertension remains very low
